Oral Sulforaphane Intervention Protects Against Diabetic Cardiomyopathy in db/db Mice: Focus on Cardiac Lipotoxicity and Substrate Metabolism
Open Access
- 16 May 2025
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 14 (5) , 603
Abstract
The protective effect of cruciferae-derived sulforaphane (SFN) on diabetic cardiomyopathy (DCM) has garnered increasing attention. However, no studies have specifically explored its mechanistic involvement in cardiac substrate metabolism and mitochondrial function. To address this gap, Type 2 diabetes mellitus (T2DM) db/db mice were orally gavaged with vehicle or 10 mg/kg body weight SFN every other day for 16 weeks, with vehicle-treated wild-type mice as controls. SFN intervention (SFN-I) alleviated hyperglycemia, dyslipidemia, HOMA-IR, serum MDA levels, and liver inflammation. Furthermore, SFN-I improved the lipotoxicity-related phenotype of T2DM cardiomyopathy, manifested as attenuation of diastolic dysfunction, cardiac injury, fibrosis, lipid accumulation and peroxidation, ROS generation, and decreased mitochondrial complex I and II activities and ATP content, despite having no effect on ceramide abnormalities. Protein expression data revealed that the model mice exhibited upregulated cardiac CD36, H-FABP, FATP4, CPT1B, PPARα, and PDK4 but downregulated GLUT4, with unchanged MPC1 and MPC2. Notably, SFN-I significantly attenuated the increase in CD36, H-FABP, CPT1B, and PPARα. These results suggest that chronic oral SFN-I protects against DCM by mitigating overall metabolic dysregulation and inhibiting cardiolipotoxicity. The latter might involve controlling cardiac fatty acid metabolism and improving mitochondrial function, rather than promoting glucose metabolism.Keywords
Funding Information
- National Natural Science Foundation (81573143, 81872612)
This publication has 86 references indexed in Scilit:
- Sulforaphane prevents diabetes‐induced hepatic ferroptosis by activating Nrf2 signaling axisBioFactors, 2024
- Sulforaphane Improves Lipid Metabolism by Enhancing Mitochondrial Function and Biogenesis In Vivo and In VitroMolecular Nutrition & Food Research, 2021
- Sulforaphane Balances Ca2+ Homeostasis Injured by Excessive Fat via Mitochondria‐Associated Membrane (MAM)Molecular Nutrition & Food Research, 2021
- The protective effect of sulforaphane on type II diabetes induced by high‐fat diet and low‐dosage streptozotocinFood Science & Nutrition, 2020
- Targeting PLIN2/PLIN5‐PPARγ: Sulforaphane Disturbs the Maturation of Lipid DropletsMolecular Nutrition & Food Research, 2019
- Potential effects of sulforaphane to fight obesityJournal of the Science of Food and Agriculture, 2018
- Sulforaphane induces adipocyte browning and promotes glucose and lipid utilizationMolecular Nutrition & Food Research, 2016
- Glucose Transporters in Cardiac Metabolism and HypertrophyComprehensive Physiology, 2016
- Diet rich in high glucoraphanin broccoli reduces plasma LDL cholesterol: Evidence from randomised controlled trialsMolecular Nutrition & Food Research, 2015
- Isothiocyanate‐rich Moringa oleifera extract reduces weight gain, insulin resistance, and hepatic gluconeogenesis in miceMolecular Nutrition & Food Research, 2015